UltraGreen.ai

Stock to watch: UltraGreen.ai

2026-09-17T00:13:56.000Z
UltraGreen.ai filed for a US$377.1 million IPO on SGX last year with an offer price of US$1.45, but the stock’s value has fallen since then.

UltraGreen.ai says it remains focused on maintaining market share in the US amid stiff competition

2026-09-16T12:07:45.000Z
In August alone, UltraGreen.ai scooped up nearly 2.2 million shares from the market for US$1.6 million, or US$0.748 apiece.
HOCK LOCK SIEW

‘Show me’ market: UltraGreen.ai should ditch its share buybacks for proactive engagement

2026-09-09T00:12:28.000Z
Ultragreen.ai has a regulatory footprint in more than 43 countries throughout Europe, the Middle East and Asia.

UltraGreen.ai to tailor response to US rivals’ pricing and distribution

2026-08-24T11:50:55.000Z
UltraGreen.ai forecasts revenue in the second half to exceed that in the first half.
HOT STOCK

UltraGreen.ai shares end 13.4% higher after week of heavy losses

2026-08-24T02:01:26.000Z
Listed last December, UltraGreen.ai is exactly the kind of growth-oriented company MAS and SGX have been trying to attract to revitalise the local market.
MARK TO MARKET

UltraGreen.ai’s big slump: Was it the Singapore market that failed the company, or vice versa?

2026-08-23T08:25:21.000Z
UltraGreen.ai has about 83% of ICG dye market share in the US, says Jamal Aliyev, an independent analyst.

UltraGreen.ai faces new competition in US market, possible pricing pressure

2026-08-19T07:53:50.000Z
CEO and executive director Ravinder Sajwan says UltraGreen.ai remains “confident of delivering double-digit growth" for FY2026.

UltraGreen.ai net profit rises 53% to US$39.2 million in H1, led by higher sales growth

2026-08-12T14:00:22.000Z
UltraGreen.ai notes that clinical adoption of indocyanine green is growing, with regulatory approvals of Verdye expanding to 40 countries.

UltraGreen.ai earnings rise 35% to US$75.6 million for FY2025

2026-02-26T13:29:04.000Z
With last month’s Singapore listing of UltraGreen.ai, a company that sells fluorescent dye used in surgical imaging, CEO Ravinder Sajwan has struck gold.

Singapore CEO’s family gains US$1.2 billion fortune from blockbuster IPO

2026-01-28T06:29:05.000Z